2. The costs of lawsuit shall be borne by the Plaintiff.

A. The plaintiff (formerly: D) is a company aimed at the development, manufacture, and sales of bio-mar medicine. Eul is the chairperson of the so-called G group substantially controlling the plaintiff and the F as an affiliate, the defendant B is the vice-chairperson of G group and H, and the defendant C is the head of the defendant B.

B. E was indicted due to the violation of the Act on the Aggravated Punishment, etc. of Specific Economic Crimes (Embezzlement), the violation of the Act on the Punishment, etc. of Specific Economic Price (Misappropriation), and the violation of the Financial Investment Services and Capital Markets Act. Among them, the criminal facts related to the Plaintiff’s request (hereinafter “each criminal facts of this case”) are as follows.

1) Embezzlement in collusion with the J for the purpose of acquiring shares in the I Savings Bank, in order to promote the medical business, Embezzlement used some of D’s specific purpose of use for the purpose of acquiring shares in the I Savings Bank as shares purchase funds necessary to secure the management rights of the I Savings Bank located in ASEAN. From March 25, 2010, E and J conspiredd with the KJ for the purpose of using 3.5 billion won in the form of a check in the form of a 3.5 billion won out of the above payment in the form of a 3.5 billion won in the form of a 3.5 billion won in the form of a 3.5 billion won in the form of a 3.5 billion won in the form of a 3.5 billion won in the form of a 3.4 billion won in the form of a 3.5 billion won in the form of a 3.4 billion won in the form of a 3.5 billion won in the form of a 3.5 billion won in the form of a I Savings Bank.